TAG:
lab acquisition
Dynacare Expands Into Chicago With Purchase of 2 Small Labs
By Robert Michel | From the Volume VIII No. 11 – August 13, 2001 Issue
IT’S A BUSINESS STRATEGY BUILT AROUND “go where they ain’t!” In recent years, Dynacare, Inc. has found its best growth comes from acquiring laboratories in areas somewhat underserved by larger national competitors. It then uses that regional base to expand outward into nearb…
DIANON Acquires UroCor And Boosts Urology Share
CEO SUMMARY: Following years of intense competition for the diagnostic testing business of office-based urologists, DIANON Systems and UroCor will now join forces. The recently-announced merger creates a powerhouse anatomic pathology company in the urology-based diagnostics services marke…
Public Labs Enjoy Boom Times As Revenues & Profits Climb
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
TAKEN COLLECTIVELY, second quarter earnings reports by public lab and pathology companies send a strong message: the lab industry is in the midst of a revenue and profit boom. It’s been more than a decade since every public lab and pathology company reported strong growth in both revenues and oper…
Unilab Files Registration For IPO of $115 Million
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: During the 1990s, Unilab used the twin strategies of lab acquisitions and aggressive sales and marketing to fuel rapid growth in specimen volumes and net revenues. However, California’s ultra-competitive managed care market and severe financial problems during the latter ha…
Specialty Labs and Dynacare Have Balance Sheet Differences
By Robert Michel | From the Volume VIII No. 5 – April 9, 2001 Issue
SINCE LAST FALL’S SUCCESSFUL IPOs (initial public offering) raised $92 million for Specialty Laboratories, Inc. and $50 million for Dynacare, Inc., the financial fortunes of the two lab companies have begun moving in different directions. Lab administrators and pa…
DIANON Systems, IMPATH, Specialty Labs, Dynacare, Quest, LabCorp
By Robert Michel | From the Volume VIII No. 3 – February 26, 2001 Issue
DIANON & IMPATH REPORT 2000 EARNINGS TWO OF THE NATIONAL anatomic pathology companies reported fourth quarter earnings. Both DIANON Systems, Inc. and IMPATH, Inc. posted big gains in revenues and operating profits for 2000. At DIANON Systems, revenues r…
Dynacare’s Business Plan Includes New Direction
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: Look for Dynacare, Inc. to undergo a significant transformation. Although it will not abandon its efforts to partner with hospital laboratories, Dynacare has made a renewed commitment to expand and market itself as a provider of esoteric and reference testing. These changes a…
Medical Arts Lab Opts To File For Chapter 11 Bankruptcy
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: Dissident shareholders and a crushing debt burden are the reason Medical Arts Laboratory decided to file for reorganization under Chapter 11 bankruptcy laws. Both factors are the legacy of an ill-fated attempt to create a national laboratory organization between 1994 and 1997…
Dynacare Sets Sights On Raising $89 Million
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care cont…
LabCorp Buys Two More California Laboratories
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Laboratory Corporation of America is serving notice that it intends to increase its competitive presence in California, the largest market for diagnostic testing in the United States. It recently signed agreements to purchase two respected independent laboratory companies, on…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized